Consolidated Planning Corp’s AbbVie ABBV Stock Holding History

Consolidated Planning Corp’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Sell	1,704 -8	-0.5%	-$1.72K	0.06%	106
2026 Q1	$372K	Buy	1,712 +433	+34%	+$96K	0.06%	107
2025 Q4	$292K	Sell	1,279 -50	-4%	-$11.4K	0.03%	177
2025 Q3	$308K	Buy	1,329 +24	+2%	+$4.89K	0.03%	163
2025 Q2	$242K	Sell	1,305 -422	-24%	-$78.4K	0.03%	172
2025 Q1	$362K	Sell	1,727 -133	-7%	-$25.9K	0.05%	145
2024 Q4	$331K	Sell	1,860 -228	-11%	-$41.9K	0.05%	158
2024 Q3	$412K	Buy	2,088 +237	+13%	+$44.2K	0.06%	136
2024 Q2	$317K	Sell	1,851 -406	-18%	-$67.3K	0.05%	137
2024 Q1	$411K	Sell	2,257 -1,212	-35%	-$209K	0.07%	115
2023 Q4	$538K	Sell	3,469 -2,155	-38%	-$314K	0.1%	104
2023 Q3	$838K	Sell	5,624 -685	-11%	-$101K	0.19%	92
2023 Q2	$850K	Buy	+6,309	New	+$925K	0.18%	96
2021 Q4	–	Sell	-1,049	Closed	-$113K	–	65
2021 Q3	$113K	Buy	+1,049	New	+$120K	0.07%	91

Other funds holding ABBV

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

HCM

Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return

AAMU

AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

FWCM

Ferguson Wellman Capital Management Portland, Oregon $8.19B AUM 30.56% 1-Year Est. Return

Consolidated Planning Corp's ABBV Position: Q2 2026 in Review

Consolidated Planning Corp reduced its AbbVie (ABBV) stake by 0.47% in Q2 2026, selling an estimated $1.72K and leaving 1,704 shares worth $429K. The position accounts for 0.06% of the portfolio, ranked #106.

Consolidated Planning Corp first reported a position in ABBV in Q3 2021 and has held it in 14 quarters since. The position peaked at $850K in Q2 2023. 1,476 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Consolidated Planning Corp held 1,704 shares of AbbVie worth $429K as of Q2 2026.
Consolidated Planning Corp sold 8 AbbVie shares in Q2 2026, an estimated $1.72K.
AbbVie made up 0.06% of Consolidated Planning Corp's portfolio in Q2 2026, its #106 holding.
Consolidated Planning Corp first reported a position in AbbVie in Q3 2021 and has held it in 14 quarters since.
Consolidated Planning Corp's AbbVie position peaked at $850K in Q2 2023.
1,476 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Consolidated Planning Corp's 13F filing for Q2 2026, filed 24 Jul 2026.